Enveric Biosciences, Inc. (ENVB)
Nasdaq: ENVB · CIK 0000890821 · United States
Every official Enveric Biosciences, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ENVB filings
Enveric Biosciences, Inc. documents
- Enveric Biosciences, Inc. 10-K 2026ENVB 10-K 2026: annual report for fiscal 2026
- Enveric Biosciences, Inc. 10-K 2025ENVB 10-K 2025: annual report for fiscal 2025
- Enveric Biosciences, Inc. 10-K 2024ENVB 10-K 2024: annual report for fiscal 2024
- Enveric Biosciences, Inc. 10-K 2023ENVB 10-K 2023: annual report for fiscal 2023
- Enveric Biosciences, Inc. 10-K 2022ENVB 10-K 2022: annual report for fiscal 2022
- Enveric Biosciences, Inc. 10-Q 2026ENVB 10-Q 2026: quarterly report for fiscal 2026
- Enveric Biosciences, Inc. 10-Q 2025ENVB 10-Q 2025: quarterly report for fiscal 2025
- Enveric Biosciences, Inc. 10-Q 2024ENVB 10-Q 2024: quarterly report for fiscal 2024
- Enveric Biosciences, Inc. 10-Q 2023ENVB 10-Q 2023: quarterly report for fiscal 2023
- Enveric Biosciences, Inc. 10-Q 2022ENVB 10-Q 2022: quarterly report for fiscal 2022
- Enveric Biosciences, Inc. 8-K 2026ENVB 8-K 2026: current report for fiscal 2026
- Enveric Biosciences, Inc. 8-K 2025ENVB 8-K 2025: current report for fiscal 2025
- Enveric Biosciences, Inc. 8-K 2024ENVB 8-K 2024: current report for fiscal 2024
- Enveric Biosciences, Inc. 8-K 2023ENVB 8-K 2023: current report for fiscal 2023
- Enveric Biosciences, Inc. 8-K 2022ENVB 8-K 2022: current report for fiscal 2022
- Enveric Biosciences, Inc. DEF 14A 2026ENVB DEF 14A 2026: proxy statement for fiscal 2026
- Enveric Biosciences, Inc. DEF 14A 2025ENVB DEF 14A 2025: proxy statement for fiscal 2025
- Enveric Biosciences, Inc. DEF 14A 2024ENVB DEF 14A 2024: proxy statement for fiscal 2024
- Enveric Biosciences, Inc. DEF 14A 2023ENVB DEF 14A 2023: proxy statement for fiscal 2023
- Enveric Biosciences, Inc. DEF 14A 2022ENVB DEF 14A 2022: proxy statement for fiscal 2022
- Enveric Biosciences, Inc. Form 4 2026ENVB Form 4 2026: insider trading filing for fiscal 2026
- Enveric Biosciences, Inc. Form 4 2025ENVB Form 4 2025: insider trading filing for fiscal 2025
- Enveric Biosciences, Inc. Form 4 2024ENVB Form 4 2024: insider trading filing for fiscal 2024
- Enveric Biosciences, Inc. Form 4 2023ENVB Form 4 2023: insider trading filing for fiscal 2023
- Enveric Biosciences, Inc. Form 4 2022ENVB Form 4 2022: insider trading filing for fiscal 2022
- Enveric Biosciences, Inc. S-1 2026ENVB S-1 2026: registration statement for fiscal 2026
- Enveric Biosciences, Inc. S-1 2025ENVB S-1 2025: registration statement for fiscal 2025
- Enveric Biosciences, Inc. S-1 2024ENVB S-1 2024: registration statement for fiscal 2024
- Enveric Biosciences, Inc. S-1 2023ENVB S-1 2023: registration statement for fiscal 2023
- Enveric Biosciences, Inc. S-1 2022ENVB S-1 2022: registration statement for fiscal 2022
- Enveric Biosciences, Inc. 13F 2026ENVB 13F 2026: institutional holdings for fiscal 2026
- Enveric Biosciences, Inc. 13F 2025ENVB 13F 2025: institutional holdings for fiscal 2025
- Enveric Biosciences, Inc. 13F 2024ENVB 13F 2024: institutional holdings for fiscal 2024
- Enveric Biosciences, Inc. 13F 2023ENVB 13F 2023: institutional holdings for fiscal 2023
- Enveric Biosciences, Inc. 13F 2022ENVB 13F 2022: institutional holdings for fiscal 2022
More companies